Evidence map›Paper›PMID 31782392›Full record

ArticleThe Lancet. Infectious diseases2019

Identification of Streptococcus pyogenes M1

Walter Demczuk, Irene Martin, Francesca Reyes Domingo, Diane MacDonald, Michael R Mulvey

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Whole Genome Sequencing Analysis of Group AJournal of Korean medical science · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Core-genome Single-nucleotide Polymorphism Analysis ofAnnals of laboratory medicine · 2025
    Article
  9. Analysis ofmBio · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Characterization ofMicroorganisms · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Invasive Group A Streptococcus Hypervirulent M1Emerging infectious diseases · 2024
    Article
  19. Article
  20. Divergent effects ofJournal of clinical microbiology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Walter DemczukPublic Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada.
Irene MartinPublic Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada. Electronic address: irene.martin@canada.ca.
Francesca Reyes DomingoCentre for Immunization and Respiratory Infectious Diseases, Ottawa, ON, Canada.
Diane MacDonaldCentre for Immunization and Respiratory Infectious Diseases, Ottawa, ON, Canada.
Michael R MulveyPublic Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Scarlet FeverStreptococcal InfectionsCanadaEnglandEpidemiologic StudiesHumansStreptococcus pyogenesUnited Kingdom

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.